Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 818 matches for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

Oxford licenses Rift Valley fever vaccine candidate amid West Africa outbreak

The University of Oxford has licensed an investigational Rift Valley fever vaccine candidate to the Serum Institute of India (SII) as outbreaks of the disease continue in parts of West Africa.

New animation explains 5 principles of good sleep health

A short animation based on research by Professor Colin Espie, explores how ‘better sleep’ can fundamentally improve our health and wellbeing

Night-time changes in metabolism may be driving common liver disease

Researchers at the University of Oxford have discovered that the most common liver disease follows a strong day-night pattern, and the metabolic changes that drive the disease are most pronounced overnight, when the body is least able to process sugar and fat.

NIHR Oxford Senior Research Fellows named

Several Medical Sciences mid-career researchers identified as having the potential to become future translational research leaders have been appointed as the next cohort of NIHR Oxford Senior Research Fellows.

Stopping weight-loss drugs linked to faster regain than ending diet programmes finds new review

People tend to regain weight rapidly after stopping weight-loss drugs – and faster than after ending behavioural weight loss programmes – according to a new systematic review and meta-analysis from department researchers published in The BMJ today.

Maternal death rates in the UK 20% higher in 2022-24 than 2009-11

The latest set of data presented by the Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries across the UK (MBRRACE-UK) Collaboration investigation into maternal deaths in the UK shows that the mortality rate for women who died during or soon after pregnancy between 2022 and 2024 was 20% higher than the maternal death rate between 2009 and 2011, when the UK government set an ambition to halve the rate of maternal deaths in England by 2025.

Oxford recruits first participant in Europe for heart inflammation treatment study

FORTIFY is an international clinical trial to test a potential treatment for people with coronary inflammation. The first patient in Europe has been recruited by the team at the Acute Multidisciplinary Imaging and Interventional Centre (AMIIC). AMIIC is a state-of-the art facility in the Radcliffe Department of Medicine linking interventional, non-invasive imaging and artificial intelligence/big data capabilities.

Oxford researchers introduce a new biomarker of intravascular haemolysis and a rapid, urine-based test for accessible diagnostics

Working with Camtech Innovations, the licensee of Oxford’s technology, researchers in the Department of Physiology, Anatomy & Genetics (DPAG) have developed and tested a lateral flow device for detecting the biomarker.

New study estimates NHS England spends 3% of its primary and secondary care budget on the health impacts of temperature

A new University of Oxford-led study, published in The Lancet Planetary Health, is the first to link daily temperature data to health-care use and costs across primary and secondary care in England. Analysis of 4.37 million patient records in England has found resources asymmetrically impacted by winter cold and summer heat, with about 64% linked to common cold days while very hot days drive sharp same-day demand surges.

Driving the development of new tools to combat Nipah virus outbreaks

PSI’s Nipah Virus Research Day showcased promising developments, spanning new insights into Nipah virus biology, clinical trials of vaccines, the development of policy responses, and progress in developing diagnostics and treatments, which are helping improve responses to outbreaks of this deadly virus.

Kennedy researchers contribute to UK-wide AI and bioscience training initiative

Together with a group of Oxford researchers, Mark Coles, Professor of Immunology at the Kennedy Institute, will co-lead the Enabling Next-generation AI for a Bioscience-Led Economy (ENAIBLE) initiative.

New study offers breakthrough in detecting risk for psychosis and bipolar disorders

A study published recently in The Lancet Psychiatry has unveiled a new approach to identifying individuals at risk of developing psychotic disorders or bipolar disorder.

International collaboration launches largest-ever therapeutics trial for patients hospitalised with dengue

A landmark international research collaboration has launched the largest clinical trial ever conducted to test therapeutics for moderate-severe dengue, a mosquito-borne viral disease that continues to spread rapidly driven by climate change and globalisation.

Oxford University and Brazil Ministry of Health Sign Letter of Intent to strengthen cancer care across Brazil

The Ministry of Health of Brazil and Oxford’s Centre for Immuno-Oncology, part of the Nuffield Department of Medicine, have signed a Letter of Intent establishing a broad collaboration to advance cancer research, innovation and clinical translation. The agreement builds on the UK-Brazil Government Health Partnership signed earlier this year, and reflects a shared commitment to accelerating research that will lead to improvements in cancer care across Brazil.

Oxford cancer researchers welcome UK AI for Science Strategy, highlighting the opportunity for national AI-ready cancer data

Oxford researchers have welcomed the UK government’s new AI for Science Strategy, which sets out an ambitious plan to harness artificial intelligence, sovereign supercomputing and high-quality scientific data to accelerate discovery in the life sciences.

Cognitive impairment after a stroke calls for tailored recovery treatment shows new study

A major new study recently published in Imaging Neuroscience shows that the brain location of the stroke does not always determine the symptoms.

Simple scoring system could help clinicians identify possible cases of NMDAR-antibody encephalitis

Scientists from across Oxford have identified a key set of symptoms and developed a scoring system to help clinicians in frontline medical and mental health services consider the possibility of a rare form of encephalitis, which can sometimes be mistaken for psychosis.

New research collaboration to tackle ethnic inequalities in perinatal severe mental illness

A ground-breaking new study aims to transform postpartum mental health care for mothers from ethnic minority backgrounds or those living in deprived areas who experience severe mental illness.

Oxford researchers develop first live-cell assay linking cancer tumour metabolism to drug effectiveness

Scientists at the Centre for Medicines Discovery, part of Oxford University’s Nuffield Department of Medicine, have developed a biosensor that, for the first time, allows researchers to directly measure how experimental cancer drugs engage their target inside living cells dependent on co-factors and metabolites.

World-leading researchers unite for ‘pivotal’ study to help children and adults with arthritis to live drug free

The prospect of long-lasting drug-free remission for children and adults living with inflammatory arthritis is a step closer to becoming a reality, thanks to a new collaboration which includes world-leading researchers from the Kennedy Institute.

Load More